SCHEMBL22563575

SCHEMBL22563575

N#Cc1c(-n2c3ccc(-c4ccccc4)cc3c3cc(-c4ccccc4)ccc32)cc(-c2nc(-c3ccccc3)cc(-c3ccccc3)n2)cc1-n1c2ccc(-c3ccccc3)cc2c2cc(-c3ccccc3)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 6/20 0.41
ADORA2A P29274 4/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
MAPK1 P28482 1/20 0.41
SQOR Q9Y6N5 3/20 0.39
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
HPGD P15428 3/20 0.39
ALDH1A1 P00352 3/20 0.39
NTSR1 P30989 1/20 0.39
MAPT P10636 1/20 0.39
KDM4E B2RXH2 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
PIM1 P11309 1/20 0.39
PPARG P37231 1/20 0.39
NCOA2 Q15596 1/20 0.39
NCOA1 Q15788 1/20 0.39
NCOA3 Q9Y6Q9 1/20 0.39
LMNA P02545 1/20 0.37
CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22563547 0.96 SQOR (0.40) ADORA1ADORA2AL3MBTL1MAPK1SQOR
SCHEMBL21278849 0.96 MEN1 (0.41) ADORA1ADORA2AL3MBTL1MAPK1SQOR
SCHEMBL22563380 0.95 ABCG2 (0.44) ADORA1ADORA2AL3MBTL1MAPK1SQOR
SCHEMBL23487313 0.94 ADORA1 (0.48) ADORA1ADORA2AL3MBTL1MAPK1SQOR
SCHEMBL22563590 0.94 MEN1 (0.44) ADORA1ADORA2AL3MBTL1MAPK1SQOR
SCHEMBL21279044 0.93 SQOR (0.39) ADORA1ADORA2AL3MBTL1MAPK1SQOR
SCHEMBL19942757 0.92 ADORA1 (0.40) ADORA1ADORA2ASQORKMT2AMEN1
SCHEMBL22563384 0.92 ABCG2 (0.41) ADORA1ADORA2AL3MBTL1MAPK1SQOR
SCHEMBL22563553 0.92 ALDH1A3 (0.46) ADORA1ADORA2AMAPK1KMT2AMEN1
SCHEMBL22563682 0.92 ALDH1A3 (0.39) ADORA1ADORA2AL3MBTL1MAPK1SQOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4498784-A2 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux, Inc. (JP) 2025-01-29 EP disclosed
EP-3775100-B1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2025-01-22 EP disclosed
US-20210175434-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2021-06-10 US disclosed
EP-3580300-B1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210175434-A1 ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, OR51E2, OCIAD2 ADORA1 4564/4885ADORA2A 4354/4885L3MBTL1 3665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.